Top compounds associated with response to TICAM1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.11 0.0003
mRNA nintedanib CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.11 0.0004
mRNA nelarabine CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.11 0.0006
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.11 0.0006
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.11 0.0008
mRNA 681640 GDSC1000 pan-cancer AAC 0.12 0.001
Download CSV